4.7 Article

A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA

期刊

BLOOD
卷 110, 期 6, 页码 1970-1981

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2006-09-044776

关键词

-

资金

  1. NIAID NIH HHS [R01 AI054128, R56 AI055677, AI55677, AI54128, R01 AI055677] Funding Source: Medline

向作者/读者索取更多资源

CpG-DNA or its synthetic analog CpGODN activates innate immunity through Toll-like receptor 9 (TLR9). However, the mechanism of TLR9 activation by CpGDNA remains elusive. Here we have identified HMGB1 as a CpG-ODN-binding protein. HMGB1 interacts and preassociates with TLR9 in the endoplasmic reticulum-Golgi intermediate compartment (ERGIC), and hastens TLR9's redistribution to early endosomes in response to CpG.. ODN. CpG-ODN stimulates macrophages; and dendritic cells to secrete HMGB1; in turn, extracellular HMGB1 accelerates; the delivery of CpG-ODNs to its receptor., leading to a TLR9-dependent augmentation of IL-6, IL-12, and TNF alpha secretion.. Loss of HMGB1 leads to a defect in the IL-6, IL-12, TNFa, and iNOS response to CpG-ODN. However, lack of intracellular TLR9-associated HMGB1 can be compensated by extracellular HMGB1. Thus, the DNA-binding protein HMGB1 shuttles in and out of immune cells and regulates inflammatory responses to CpG-DNA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据